Patient Guide: Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT01651403
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Hepatitis B
Phase: PHASE3

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • San Francisco, California
  • • Aurora, Colorado
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection - Join Clinical Trial NCTNCT01651403

How to Join This Clinical Trial - NCTNCT01651403

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Hepatitis B. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Hepatitis B. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Hepatitis B
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT01651403 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85016 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: Contact for availability

Clinical Research Site

Houston, Texas 77030 - United States

Status: Contact for availability

Clinical Research Site

Surat, Gujrat 395 002 - India

Status: Contact for availability

Clinical Research Site

Gurgaon, Haryana 122 001 - India

Status: Contact for availability

Clinical Research Site

Nagpur, Maharashtra 440012 - India

Status: Contact for availability

Clinical Research Site

Jaipur, Rajasthan 302004 - India

Status: Contact for availability

Clinical Research Site

Lucknow, Uttar Pradesh 226003 - India

Status: Contact for availability

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Hepatitis B:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships